ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 3 September 2007. doi:10.1136/adc.2006.114249
Archives of Disease in Childhood 2008;93:147-148
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
adc.2006.114249v1
93/2/147    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kapoor, R R
Right arrow Articles by Acerini, C L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kapoor, R R
Right arrow Articles by Acerini, C L
Topic Collections
Right arrow Editor's choice
Right arrowRelevant Article

Short reports

Monitoring of concordance in growth hormone therapy

R R Kapoor, S A Burke, S E Sparrow, I A Hughes, D B Dunger, K K Ong, C L Acerini

Department of Paediatrics, Addenbrooke’s Hospital, University of Cambridge, Cambridge, UK

Correspondence to:
Dr C L Acerini, Department of Paediatrics, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK; cla22{at}cam.ac.uk

Concordance with growth hormone (GH) therapy in 75 children was objectively assessed using data on GP prescriptions over 12 months. 23% missed >2 injections/week. Lower concordance was associated with longer duration on GH therapy (p<0.005), lack of choice of delivery device (p<0.005) and short prescription durations (p<0.005), and predicted lower height velocities (p<0.05).



Relevant Article

Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
Petrou and McIntosh
Arch. Dis. Child. 2008 93: 95-97. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
Petrou and McIntosh
Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
Arch. Dis. Child., February 1, 2008; 93(2): 95 - 97.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health